McKesson Ventures in the News

Wall Street Journal

Venture Investors: Theranos’s Fall Underscores Need for Transparency

Medical startups need to communicate their progress well, or they set themselves up for failure. Theranos Inc. is the most recent example of how negligence can carry big consequences. Venture capitalists and entrepreneurs attribute the company’s downfall to a failure to be transparent in dealings...

It’s California’s second richest company, but you probably haven’t heard of it

What’s the second richest company in California? If you can’t answer that question, you aren’t the only one. The answer? McKesson Corporation. According to Fortune, McKesson is “a massive corporation hiding in plain sight.” A distributor of pharmaceuticals and other medical supplies, McKesson is often overlooked...

The Next Step in Fighting Cancer: A Digital Management Platform?

While many are focused on finding a cure for cancer, making treatments more accessible to patients, and early detection or prevention—all critical elements of the cancer paradigm—one aspect of the fight against cancer needs more attention. Coordinating care across patients, physicians, payers, and specialty pharma can...

Amazon Is Showing Interest In the Healthcare Industry

The possibility of Amazon’s expansion into healthcare has some industry insiders worried. “I get asked all the time what Amazon is doing,” said Tom Rodgers, managing director of McKesson Ventures. “Everyone in the supply chain is nervous. It’s a low-level paranoia that Amazon will drive down...

VatorNews

What Digital Health Trends Are VCs Embracing and Ignoring?

A group of venture capitalists recently sat down at Vator Splash Health 2017 to discuss the latest trends in digital health. The panelists, Dave Schulte of McKesson Ventures, Patrick Chung of Xfund, Rebecca Lynn of Canvas Ventures, Michael Dixon of Sequoia Capital, and Rebecca Woodcock...

VatorNews

Personalized Medicine? We Still Have a Long Way to Go

Near the end of Vator Splash Health, Wellness and Wearables, a group of venture capitalists took to the stage to discuss which healthtech trends VCs are embracing and which are overhyped. Participants included moderator Patrick Chung of Xfund and panelists Rebecca Lynn of Canvas Ventures,...